Effect of Shatavari And Dadima In Abnormal Menstrual Bleeding In Adolescent Girls.
Phase 2
- Conditions
- Health Condition 1: E288- Other ovarian dysfunction
- Registration Number
- CTRI/2022/03/041315
- Lead Sponsor
- DRASHWINI NARAYAN KARANDIKAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Girls between 12-19 years
2.After one year of menarche
3.Having complaints of abnormal uterine bleeding : â?? irregular or scanty or excessive
bleeding and/or having inter menstrual bleeding or spotting.
Exclusion Criteria
1. Having other systemic diseases, severe anemia, congenital anomalies
2. Severe malnourishment
3. Excessive bleeding during menses causing hemodynamic instability and worsening the
general condition.
4. Participant who misses 2 follow up.
5. Participant willing to discontinue the treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method menstruation regulates or not <br/ ><br>monthly cycle 4-5 days after 28 to 30 days with normal flow according to PBAC(pictorial blood loss analysis chart) scoring for uterine bleeding before and afterTimepoint: partcipant will be assessed at baseline ,after 1st month,2nd month and 3rd month for menstrual pattern
- Secondary Outcome Measures
Name Time Method haemoglobin percentage by measuring on haemoglobinometerTimepoint: baseline and after 3 months